Co-delivery of Doxorubicin and Afatinib with pH-responsive Polymeric Nanovesicle for Enhanced Lung Cancer Therapy
Crossref DOI link: https://doi.org/10.1007/s10118-019-2272-6
Published Online: 2019-06-04
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gong, Heng-Ye
Chen, Yan-Gui
Yu, Xing-Su
Xiao, Hong
Xiao, Jin-Peng
Wang, Yong
Shuai, Xin-Tao
Text and Data Mining valid from 2019-06-04
Version of Record valid from 2019-06-04
Article History
Received: 17 March 2019
Accepted: 8 April 2019
First Online: 4 June 2019